Description

The ​mounting ​pressures ​from ​time ​to ​market, ​quality ​products ​and ​streamlined ​operations ​have ​finally ​sparked ​investments ​in ​pharmaceutical ​manufacturing. ​Following ​the ​draft ​guidance ​from ​FDA, ​new ​integrated ​continuous ​manufacturing ​(ICM) ​projects ​have ​been ​initiated ​to ​accelerate ​pilot ​projects ​to ​commercial ​scale.

Commercializing ​Continuous ​Processing ​2018 ​will ​provide ​you ​with ​the ​360o ​view ​of ​regulatory, ​commercial ​and ​technical ​landscape.

Start Your Registration